Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2.

Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2.
复制标题

DOI:
10.1007/s12079-009-0056-4
复制
发表时间:
2009-06
影响因子:
4.1
通讯作者:
Leask, Andrew
Leask, Andrew
中科院分区:
生物学2区
文献类型:
--
作者:
Leask, Andrew
关键词:

文献摘要

参考文献

被引文献

相似文献

纤维化疾病是死亡的重要原因。CCN 2(结缔组织生长因子[CTGF])是基质细胞蛋白CCN家族的成员,在驱动细胞因子如转化生长因子β(TGFβ)的纤维化作用中起重要作用。已经提出,CCN家族的其他成员可以促进或拮抗CCN 2的作用,这取决于上下文。布鲁斯·里瑟和他的同事们最近发表的一项优雅的研究(美国病理学杂志)。174:1725-34,2009)说明CCN 3(nov)拮抗CCN 2的纤维化作用。这篇评论的主题,提出了一种有趣的可能性,即CCN 3可能被用作一种新的抗纤维化疗法。
Fibrotic disease is a significant cause of mortality. CCN2 (connective tissue growth factor [CTGF]), a member of the CCN family of matricellular proteins, plays a significant role in driving the fibrogenic effects of cytokines such as transforming growth factor β (TGFβ). It has been proposed that other members of the CCN family can either promote or antagonize the action of CCN2, depending on the context. A recent elegant study published by Bruce Riser and colleagues (Am J Pathol. 174:1725–34, 2009) illustrates that CCN3 (nov) antagonizes the fibrogenic effects of CCN2. This paper, the subject of this commentary, raises the intriguing possibility that CCN3 may be used as a novel anti-fibrotic therapy.
结缔组织疾病中的纤维化:肌纤维细胞和成纤维细胞上皮细胞相互作用的作用。
DOI: 10.1186/ar2188
发表时间: 2007
影响因子: 4.9
作者:
Krieg, Thomas;Abraham, David;Lafyatis, Robert
通讯作者: Lafyatis, Robert
DOI: 10.1038/sj.emboj.7601596
发表时间: 2007-03-07
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Chen, Chih-Chiun;Young, Jennifer L.;Lau, Lester F.
通讯作者: Lau, Lester F.
DOI: 10.1016/j.yexcr.2006.12.006
发表时间: 2007-03-10
影响因子: 3.7
作者:
Kennedy, Laura;Liu, Shangxi;Leask, Andrew
通讯作者: Leask, Andrew
DOI: 10.1016/j.tibs.2008.07.006
发表时间: 2008-10
影响因子: 13.8
作者:
Holbourn KP;Acharya KR;Perbal B
通讯作者: Perbal B
DOI: 10.1074/jbc.m511343200
发表时间: 2006-04-21
影响因子: 4.8
作者:
Shi-Wen, X;Stanton, LA;Leask, A
通讯作者: Leask, A